Compare Mutual Funds
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.28
-
NAV
₹39.18
-
Fund Started
04 Dec 2015
-
Fund Size
₹1455.16 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
1 Year
8.64%
-
3 Year
20.44%
-
5 Year
13.24%
-
Equity
97.42%
-
Cash
2.58%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.51% |
Max Healthcare Institute Ltd. | 5.68% |
Healthcare Global Enterprises Ltd. | 5.52% |
Divi's Laboratories Ltd. | 5.12% |
Abbott India Ltd. | 4.97% |
Cipla Ltd. | 4.77% |
Apollo Hospitals Enterprise Ltd. | 4.61% |
Rainbow Children's Medicare Ltd. | 4.42% |
Dr. Reddy's Laboratories Ltd. | 4.26% |
Glaxosmithkline Pharmaceuticals Ltd. | 4.12% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-
